FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
No significantly increased risk seen with exposure to different triptan intensities and duration, alone or in combination with other preventive medications
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia
Topical Testosterone + Exercise No Aid for Hip Fracture Recovery in Women
Findings compared with exercise therapy alone or usual care among older women
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
Increased risk for death and relapse seen for children with overweight, obesity at two or more time points
FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL
AAP Updates Guidelines for Pediatric Atopic Dermatitis Management
Topical anti-inflammatories should be applied once to twice daily to active eczema patches
Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
No cases of endometrial, ovarian, vaginal, or vulvar cancer were seen
